MEFENAMIC ACID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mefenamic Acid, and when can generic versions of Mefenamic Acid launch?
Mefenamic Acid is a drug marketed by Belcher, Chartwell Rx, Lupin Ltd, Micro Labs, and Nostrum Labs Inc. and is included in five NDAs.
The generic ingredient in MEFENAMIC ACID is mefenamic acid. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mefenamic Acid
A generic version of MEFENAMIC ACID was approved as mefenamic acid by MICRO LABS on November 19th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEFENAMIC ACID?
- What are the global sales for MEFENAMIC ACID?
- What is Average Wholesale Price for MEFENAMIC ACID?
Summary for MEFENAMIC ACID
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 134 |
| Clinical Trials: | 16 |
| Patent Applications: | 2,859 |
| Drug Prices: | Drug price information for MEFENAMIC ACID |
| DailyMed Link: | MEFENAMIC ACID at DailyMed |
Recent Clinical Trials for MEFENAMIC ACID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Takeda | Phase 1 |
| Nuventra | Phase 1 |
| Emalex Biosciences Inc. | Phase 1 |
Pharmacology for MEFENAMIC ACID
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for MEFENAMIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for MEFENAMIC ACID
US Patents and Regulatory Information for MEFENAMIC ACID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belcher | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 091608-001 | Jun 2, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Micro Labs | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 090562-001 | Nov 19, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 209209-001 | Sep 18, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin Ltd | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 091322-001 | Jul 22, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nostrum Labs Inc | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 090359-001 | Feb 5, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
